Johann-Christoph Jann, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myelodysplastic Syndromes | 18 | 2024 | 1392 | 2.440 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2024 | 727 | 1.180 |
Why?
|
Mesenchymal Stem Cells | 5 | 2023 | 1634 | 0.950 |
Why?
|
Chromosomes, Human, Pair 5 | 5 | 2021 | 385 | 0.860 |
Why?
|
Clone Cells | 4 | 2024 | 1660 | 0.790 |
Why?
|
Cell Cycle Proteins | 2 | 2024 | 3442 | 0.760 |
Why?
|
Growth Differentiation Factor 2 | 1 | 2020 | 27 | 0.710 |
Why?
|
Myeloproliferative Disorders | 2 | 2023 | 606 | 0.630 |
Why?
|
Bone Marrow | 6 | 2024 | 2909 | 0.630 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2020 | 251 | 0.630 |
Why?
|
Leukemia, Myeloid | 1 | 2021 | 695 | 0.610 |
Why?
|
Chromosome Deletion | 5 | 2021 | 1387 | 0.590 |
Why?
|
Multipotent Stem Cells | 1 | 2019 | 200 | 0.590 |
Why?
|
Bone Marrow Cells | 3 | 2021 | 2414 | 0.530 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2024 | 3599 | 0.510 |
Why?
|
Microsatellite Repeats | 1 | 2017 | 785 | 0.480 |
Why?
|
Mutation | 12 | 2024 | 29915 | 0.480 |
Why?
|
Osteoblasts | 1 | 2020 | 1142 | 0.470 |
Why?
|
Hematopoiesis | 3 | 2021 | 2047 | 0.430 |
Why?
|
Osteogenesis | 1 | 2020 | 1271 | 0.430 |
Why?
|
Neoplasm Proteins | 2 | 2021 | 3609 | 0.340 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1890 | 0.330 |
Why?
|
Phosphoproteins | 4 | 2024 | 2433 | 0.280 |
Why?
|
Azacitidine | 2 | 2024 | 334 | 0.250 |
Why?
|
Hematopoietic Stem Cells | 5 | 2024 | 3384 | 0.240 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2024 | 141 | 0.230 |
Why?
|
Single-Cell Analysis | 3 | 2024 | 2379 | 0.200 |
Why?
|
Thalidomide | 2 | 2017 | 884 | 0.190 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2021 | 646 | 0.190 |
Why?
|
Flavonoids | 1 | 2024 | 443 | 0.180 |
Why?
|
Mosaicism | 1 | 2024 | 465 | 0.180 |
Why?
|
Caproates | 1 | 2020 | 19 | 0.180 |
Why?
|
Erythroid Precursor Cells | 1 | 2021 | 211 | 0.170 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1346 | 0.170 |
Why?
|
Aged, 80 and over | 10 | 2024 | 58683 | 0.170 |
Why?
|
Peptide Hormones | 1 | 2021 | 132 | 0.170 |
Why?
|
Benzoates | 1 | 2021 | 211 | 0.170 |
Why?
|
Blood Cells | 1 | 2021 | 305 | 0.170 |
Why?
|
Hydrazines | 1 | 2021 | 224 | 0.170 |
Why?
|
Antigens, CD | 2 | 2021 | 3997 | 0.170 |
Why?
|
Receptors, Transferrin | 1 | 2021 | 291 | 0.160 |
Why?
|
Lactones | 1 | 2020 | 317 | 0.150 |
Why?
|
Leukemia | 2 | 2022 | 1519 | 0.140 |
Why?
|
Uniparental Disomy | 1 | 2017 | 45 | 0.140 |
Why?
|
Tumor Microenvironment | 2 | 2021 | 3840 | 0.140 |
Why?
|
Alkaline Phosphatase | 1 | 2020 | 865 | 0.140 |
Why?
|
Fibronectins | 1 | 2020 | 722 | 0.130 |
Why?
|
Extracellular Matrix Proteins | 1 | 2020 | 829 | 0.130 |
Why?
|
Cell Separation | 1 | 2021 | 1720 | 0.130 |
Why?
|
Cell Differentiation | 4 | 2023 | 11471 | 0.130 |
Why?
|
Piperidines | 1 | 2024 | 1639 | 0.130 |
Why?
|
Repressor Proteins | 2 | 2024 | 2980 | 0.120 |
Why?
|
Peroxisome Proliferators | 1 | 2014 | 6 | 0.120 |
Why?
|
Aged | 14 | 2024 | 168218 | 0.120 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2016 | 179 | 0.120 |
Why?
|
Prognosis | 4 | 2024 | 29557 | 0.120 |
Why?
|
Immunophenotyping | 1 | 2019 | 1871 | 0.120 |
Why?
|
Granulosa Cells | 1 | 2014 | 115 | 0.110 |
Why?
|
Diethylhexyl Phthalate | 1 | 2014 | 83 | 0.110 |
Why?
|
Pancytopenia | 1 | 2014 | 101 | 0.110 |
Why?
|
Antilymphocyte Serum | 1 | 2014 | 482 | 0.100 |
Why?
|
Anemia, Aplastic | 1 | 2014 | 228 | 0.100 |
Why?
|
Mice, Inbred NOD | 4 | 2021 | 1825 | 0.100 |
Why?
|
Middle Aged | 12 | 2024 | 219568 | 0.100 |
Why?
|
Antineoplastic Agents | 4 | 2021 | 13591 | 0.100 |
Why?
|
Cells, Cultured | 3 | 2023 | 18940 | 0.100 |
Why?
|
Cyclosporine | 1 | 2014 | 777 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1855 | 0.100 |
Why?
|
Humans | 29 | 2024 | 758406 | 0.100 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2016 | 685 | 0.090 |
Why?
|
Blood Transfusion | 1 | 2018 | 1321 | 0.090 |
Why?
|
Flow Cytometry | 1 | 2021 | 5864 | 0.090 |
Why?
|
Endocrine Disruptors | 1 | 2014 | 263 | 0.090 |
Why?
|
Antigens, Neoplasm | 1 | 2019 | 1997 | 0.090 |
Why?
|
Pyrazoles | 1 | 2021 | 1988 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1807 | 0.090 |
Why?
|
Stem Cell Niche | 1 | 2014 | 345 | 0.090 |
Why?
|
RNA | 1 | 2020 | 2716 | 0.090 |
Why?
|
Neoplasms | 3 | 2024 | 22032 | 0.090 |
Why?
|
Cell Line | 2 | 2022 | 15591 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5786 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 3733 | 0.080 |
Why?
|
Base Sequence | 1 | 2020 | 12436 | 0.080 |
Why?
|
Mice | 9 | 2024 | 81101 | 0.080 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2019 | 1406 | 0.080 |
Why?
|
Male | 15 | 2024 | 358747 | 0.080 |
Why?
|
Female | 16 | 2024 | 390323 | 0.080 |
Why?
|
Peptides | 1 | 2020 | 4341 | 0.080 |
Why?
|
Proteomics | 1 | 2021 | 3816 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3754 | 0.080 |
Why?
|
RNA Splicing | 2 | 2024 | 913 | 0.070 |
Why?
|
Mice, SCID | 3 | 2021 | 2626 | 0.070 |
Why?
|
Genotype | 1 | 2021 | 12945 | 0.070 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9574 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4373 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2016 | 1585 | 0.070 |
Why?
|
Adult | 7 | 2024 | 219935 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7583 | 0.070 |
Why?
|
Immunoglobulin G | 1 | 2018 | 4540 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9404 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2912 | 0.060 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 1547 | 0.060 |
Why?
|
Environmental Pollutants | 1 | 2014 | 1268 | 0.060 |
Why?
|
Animals | 10 | 2024 | 167768 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16534 | 0.060 |
Why?
|
Culture Media, Serum-Free | 1 | 2023 | 148 | 0.050 |
Why?
|
DNA | 1 | 2017 | 7199 | 0.050 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2023 | 54 | 0.050 |
Why?
|
Apoptosis | 3 | 2024 | 9468 | 0.050 |
Why?
|
Genomic Structural Variation | 1 | 2022 | 63 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2013 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4158 | 0.050 |
Why?
|
Cell Proliferation | 3 | 2023 | 10416 | 0.040 |
Why?
|
K562 Cells | 1 | 2021 | 639 | 0.040 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2021 | 195 | 0.040 |
Why?
|
Erythropoiesis | 1 | 2023 | 682 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20055 | 0.040 |
Why?
|
Systems Biology | 1 | 2021 | 482 | 0.040 |
Why?
|
Gene Rearrangement | 1 | 2022 | 1122 | 0.040 |
Why?
|
Fas Ligand Protein | 1 | 2018 | 215 | 0.040 |
Why?
|
Disease Progression | 3 | 2018 | 13468 | 0.030 |
Why?
|
Deoxycytidine Kinase | 1 | 2014 | 11 | 0.030 |
Why?
|
Bezafibrate | 1 | 2014 | 14 | 0.030 |
Why?
|
Radiation Chimera | 1 | 2014 | 216 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2021 | 1737 | 0.030 |
Why?
|
Peptide Synthases | 1 | 2014 | 80 | 0.030 |
Why?
|
DNA Repair | 1 | 2024 | 2038 | 0.030 |
Why?
|
Biotransformation | 1 | 2014 | 166 | 0.030 |
Why?
|
Plasticizers | 1 | 2014 | 50 | 0.030 |
Why?
|
DNA Damage | 1 | 2024 | 2439 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6127 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2021 | 2378 | 0.030 |
Why?
|
PPAR alpha | 1 | 2014 | 175 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3574 | 0.030 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 223 | 0.030 |
Why?
|
Genome | 1 | 2021 | 1739 | 0.030 |
Why?
|
Cytarabine | 1 | 2014 | 696 | 0.030 |
Why?
|
Vincristine | 1 | 2014 | 1038 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 2014 | 725 | 0.020 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2014 | 220 | 0.020 |
Why?
|
PPAR gamma | 1 | 2014 | 482 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2023 | 3299 | 0.020 |
Why?
|
Stem Cells | 1 | 2024 | 3521 | 0.020 |
Why?
|
Thiazolidinediones | 1 | 2014 | 460 | 0.020 |
Why?
|
Signal Transduction | 1 | 2014 | 23342 | 0.020 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 381 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6493 | 0.020 |
Why?
|
Gene Dosage | 1 | 2014 | 1218 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11709 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2016 | 14354 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1745 | 0.020 |
Why?
|
Genetic Variation | 1 | 2024 | 6548 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1136 | 0.020 |
Why?
|
Methotrexate | 1 | 2014 | 1719 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3584 | 0.020 |
Why?
|
Ligands | 1 | 2014 | 3258 | 0.020 |
Why?
|
Dexamethasone | 1 | 2014 | 1927 | 0.020 |
Why?
|
Estradiol | 1 | 2014 | 1933 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3615 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12440 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9599 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10748 | 0.020 |
Why?
|
Aging | 1 | 2024 | 8650 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18358 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2021 | 64378 | 0.010 |
Why?
|
Transcription Factors | 1 | 2024 | 12094 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4711 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6768 | 0.010 |
Why?
|
Prospective Studies | 2 | 2018 | 54137 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18119 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22029 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2014 | 5249 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15651 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39059 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11892 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15773 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 58808 | 0.010 |
Why?
|